Product Images Fasenra
View Photos of Packaging, Labels & Appearance
- fasenra_30mg_mL_single-dose_prefilled_syringe_carton - fasenra 30 mg mL carton
- FasenraPen-30mg_ml_single_dose_autoinjector_carton - fasenrapen 30mg ml single dose autoinjector carton
- Figure 2 - figure 02
- figure_3_change_from_baseline_fev1 - figure 3 change from baseline fev1
- Figure 1 prefilled syringe components - image 01
- Step 2 needle cover image - image 02
- Step 3 - image 03
- Step 4 - image 04
- Step 5 - image 05
- step 10 sharps container
- step 1 gather supplies
- step 2 30 minute clock
- step 3 fasenra pen viewing window
- step 4 choose the injection site
- step 5 clean the injection site
- step 6 pull off the cap
- step 7 a position the pen at the injection site
- step 7 b position press down firmly
- step 7 c hold down firmly for 15 seconds
- step 7 d lift the fasenra pen straight up
- step 8 check the viewing window
- step 8 viewing window after injection
- step 8 viewing window before injection
- step 9 check the injection site
- your fasenra pen after use
- your fasenra pen before use
Product Label Images
The following 26 images provide visual information about the product associated with Fasenra NDC 0310-1745 by Astrazeneca Pharmaceuticals Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
fasenra_30mg_mL_single-dose_prefilled_syringe_carton - fasenra 30 mg mL carton

Fasenra is a prescription medication that contains benralizumab and is intended for subcutaneous injection only. The prefilled syringe should be stored in a refrigerator and protected from light, between 36°F - 46°F (2°C - 8°C) and should not be shaken, frozen, or exposed to heat. The provided NDC code is 0310-1730-30.*
FasenraPen-30mg_ml_single_dose_autoinjector_carton - fasenrapen 30mg ml single dose autoinjector carton

NDG 0s10-1830-30 Rxonly is a prescription medication called Fasenra Pen. It is an injection with a concentration of 30mg/mL that is stored in a refrigerator at a temperature between 2°C and 8°C. It is only for subcutaneous injection, and users should not expose it to heat or light and must follow the instructions enclosed to prepare and deliver their dose.*
figure_3_change_from_baseline_fev1 - figure 3 change from baseline fev1

This text seems to present the change in Forced Expiratory Volume in one second (FEV1) in liters for a study involving a medicine called Benraqew compared to a placebo. There are results for different time points until 56 weeks. There is also a statement indicating that Fasenra has a significant difference in relation to the placebo, with a nominal p-value of less than 0.05.*
Figure 1 prefilled syringe components - image 01

The text describes a syringe label brand called "Needleguard" that has a needle cover and activation clips. The syringe has a plunger head and a finger flange window for viewing the needle. The body of the syringe has an expiration date.*
your fasenra pen after use

After use, a needle green guard plunger is needed to maintain safety measures.*
your fasenra pen before use

This text provides instructions for using a liquid medicine. It suggests checking the expiration date on the label and includes a reference to a viewing window, presumably to check the medicine's color or quantity. It appears to be part of the instructions for use and is likely found on the packaging or label of a liquid medication.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.